1. Breast cancer stem cell: the roles and therapeutic implications
    Fang Yang et al, 2017, Cell. Mol. Life Sci. CrossRef
  2. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Bowen Du et al, 2016, Molecules CrossRef
  3. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
    Dan Lin et al, 2017 CrossRef
  4. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells
    Ningning Yan et al, 2017, Experimental Cell Research CrossRef
  5. Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack
    Pritish Nilendu et al, 2018, Int. J. Cancer CrossRef
  6. Yeast casein kinase 2 governs morphology, biofilm formation, cell wall integrity, and host cell damage of Candida albicans
    Sook-In Jung et al, 2017, PLoS ONE CrossRef
  7. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC)
    Pan Jiang et al, 2017 CrossRef
  8. NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1
    Pan Jiang et al, 2018, J Cell Physiol CrossRef
  9. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway
    Xiaoting Li et al, 2018, J. Cell. Biochem. CrossRef
  10. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin
    Long Cui et al, 2018, The American Journal of the Medical Sciences CrossRef
  11. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
    Tathiane M. Malta et al, 2018, Cell CrossRef
  12. Signalling mechanism(s) of epithelial–mesenchymal transition and cancer stem cells in tumour therapeutic resistance
    Zhihong Cai et al, 2018, Clinica Chimica Acta CrossRef
  13. Self-renewal signaling pathways in breast cancer stem cells
    Lakshmi vineela Nalla et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  14. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
    Hao-Feng Gu et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
  15. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
    Jerry Harb et al, 2019, Curr Oncol Rep CrossRef
  16. Inhibition of cytosolic phospholipase A2 alpha increases chemosensitivity in cervical carcinoma through suppressing β-catenin signaling
    Hai Xu et al, 2019, Cancer Biology & Therapy CrossRef
  17. Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
    Masahiro Shibata et al, 2019, Cancers CrossRef
  18. Activation of Wnt signaling promotes olaparib resistant ovarian cancer
    Tomomi M. Yamamoto et al, 2019, Mol Carcinog CrossRef
  19. Lumiflavin increases the sensitivity of ovarian cancer stem‐like cells to cisplatin by interfering with riboflavin
    Ruhui Yang et al, 2019, J Cell Mol Med CrossRef
  20. Casein kinase 1α-dependent inhibition of Wnt/β-catenin selectively targets nasopharyngeal carcinoma and increases chemosensitivity
    Jiangping Li et al, 2019, Anti-Cancer Drugs CrossRef
  21. The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
    David Rodriguez et al, 2019, Cancers (Basel) CrossRef
  22. Integrative analysis of gene expression and DNA methylation through one‐class logistic regression machine learning identifies stemness features in medulloblastoma
    Hao Lian et al, 2019, Mol Oncol CrossRef
  23. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling
    Shaojie Jiang et al, 2019, Cell Commun Signal CrossRef
  24. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
    Chongyuan Zhang et al, 2017, Med Sci Monit CrossRef
  25. miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
    Hailin Tang et al, 2019, J Cell Mol Med CrossRef
  26. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy
    Kevin Dzobo et al, 2019, OMICS: A Journal of Integrative Biology CrossRef
  27. Targeting Breast Cancer Stem Cells: A Methodological Perspective
    Marco A. Velasco-Velázquez et al, 2019, CSCR CrossRef
  28. Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells
    A Karamian et al, 2019, Hum Exp Toxicol CrossRef
  29. Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs
    Qing Guan et al, 2020, Emerging Microbes & Infections CrossRef
  30. Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair
    Edward J. Jarman et al, 2020, Expert Opinion on Investigational Drugs CrossRef
  31. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog /Gli and Wnt/ β-catenin signaling crosstalk
    Marwa O. El-Derany et al, 2020, Biochemical Pharmacology CrossRef
  32. HINT2 downregulation promotes colorectal carcinoma migration and metastasis
    Weihua Li et al, 2017, Oncotarget CrossRef
  33. Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells
    Ningning Yan et al, 2017, Oncotarget CrossRef
  34. Emerging agents that target signaling pathways in cancer stem cells
    Yue Yang et al, 2020, J Hematol Oncol CrossRef
  35. Involvement of breast cancer stem cells in tumor angiogenesis
    Yu Wang et al, 2017, Oncol Lett CrossRef
  36. Long non‑coding RNA profile revealed by microarray indicates that lncCUEDC1 serves a negative regulatory role in breast cancer stem cells
    Fengchun Zhang et al, 2020, Int J Oncol CrossRef
  37. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
    Sebastien Taurin et al, 2020, Neoplasia CrossRef
  38. Drug Repurposing for Triple-Negative Breast Cancer
    Marta Ávalos-Moreno et al, 2020, JPM CrossRef
  39. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Ya Zhang et al, 2020, J Hematol Oncol CrossRef
  40. Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
    Rosanna Dattilo et al, 2020, Cancer Res CrossRef
  41. Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate – An example of breast cancer
    Shu-Wei Huang et al, 2021, Journal of Microbiology, Immunology and Infection CrossRef
  42. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
    Li Lv et al, 2021, IJN CrossRef
  43. LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells
    Nadia Flores-Huerta et al, 2021, Biomolecules CrossRef
  44. A Wnt-mediated phenotype switch along the epithelial–mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma
    Fatemeh Zolghadr et al, 2021, Br J Cancer CrossRef
  45. Signaling pathways governing breast cancer stem cells behavior.
    Kai Song et al, 2021, Stem Cell Res Ther CrossRef
  46. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
  47. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy
    Zhuo Wang et al, 2021, Biomark Res CrossRef
  48. null
    Nahida Siddiqui et al, 2021 CrossRef
  49. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
    Ann Neiheisel et al, 2021, Int. J. Cancer CrossRef
  50. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer
    Ankita Dey et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  51. Dual drug targeting to kill colon cancers
    Silvia Paola Corona et al, 2022, Cancer Medicine CrossRef
  52. OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice
    Wei Peng et al, 2022, Front. Oncol. CrossRef
  53. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR
    Baohong Jiang et al, 2022, ACAMC CrossRef
  54. DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer
    Jianan Zhang et al, 2022, Front. Oncol. CrossRef
  55. Fate decisions of breast cancer stem cells in cancer progression
    Hui Xu et al, 2022, Front. Oncol. CrossRef
  56. Targeting Wnt/β-catenin signaling pathway in triple-negative breast cancer by benzylic organotrisulfides: Contribution of the released hydrogen sulfide towards potent anti-cancer activity
    Debojit Bhattacherjee et al, 2022, Free Radical Biology and Medicine CrossRef
  57. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
    Shipra Singhal et al, 2022, ACAMC CrossRef
  58. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
    Patricia Cámara-Sánchez et al, 2022, IJMS CrossRef
  59. A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis
    Zeinab Mazloumi et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  60. The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression
    Samuel J. Rodgers et al, 2022, Cancers CrossRef
  61. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
    Mehrdad Hashemi et al, 2023, International Journal of Biological Macromolecules CrossRef
  62. Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer
    Natalia Landeros et al, 2023, Cells CrossRef
  63. Breast cancer stem cells: Biology and therapeutic implications.
    Ramesh Butti et al, 2019, Int J Biochem Cell Biol CrossRef
  64. Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
    Nives Pećina-Šlaus et al, 2023, IJMS CrossRef
  65. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review
    Keihan Afshari et al, 2023, Cancer Control CrossRef
  66. A novel cross-communication of HIF-1α and HIF-2α with Wnt signaling in TNBC and influence of hypoxic microenvironment in the formation of an organ-on-chip model of breast cancer
    Manosi Banerjee et al, 2023, Med Oncol CrossRef
  67. null
    Rishabha Malviya et al, 2023 CrossRef
  68. Molecular targets and therapeutic strategies for triple-negative breast cancer
    Yashasvi Bhat et al, 2023, Mol Biol Rep CrossRef
  69. The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer
    Yiyi Ji et al, 2023, Nat Commun CrossRef
  70. Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics
    Shraddha Shravani Peri et al, 2023, Cancers CrossRef
  71. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
    Iván Carrera-Aguado et al, 2024, IJMS CrossRef
  72. Genetic landscape of breast cancer subtypes following radiation therapy: insights from comprehensive profiling
    Fang Wang et al, 2024, Front. Oncol. CrossRef
  73. Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications
    Bhasker Dharavath et al, 2024, npj Precis. Onc. CrossRef
  74. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification
    Peng Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef